Navigation

Press releases

The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.

Results 141-150 of 856

Breast cancer drug not cost effective for NHS, says draft NICE guidance
The cancer drug everolimus (Afinitor, Novartis Pharmaceuticals) is not recommended as an NHS-funded treatment for a type of advanced breast cancer because it is not good value for money, says latest draft guidance from NICE.
July 8, 2013

NICE consults on advice to help care homes support mental wellbeing of vulnerable older people
The National Institute for Health and Care Excellence (NICE) is developing advice for care homes to help them promote the mental wellbeing of older people by supporting and empowering those they look after.
July 5, 2013

A one-size fits all approach to measure body mass does not work in our diverse population, says NICE
The National Institute for Health and Care Excellence says Body Mass Index, a standard core measure used to identify risk of conditions such as type 2 diabetes or heart disease, may be being applied wrongly to people from black, Asian and other minority ethnic groups.
July 3, 2013

Standards of care for people who self-harm must be improved, says NICE
The National Institute for Health and Care Excellence (NICE) has published a quality standard to improve the quality of care and support for children, young people, and adults who self-harm.
June 28, 2013

Advice from NICE supports improved commissioning for people who self-harm
NICE's support for commissioning for self-harm will help commissioners to drive up quality and ensure that the needs of people who self-harm are being addressed in the range of generic services they commonly use.
June 28, 2013

NICE guidance to eradicate the postcode lottery of treatment for a type of severe bowel disease
A ?postcode lottery? of treatment should become a thing of the past for sufferers of an incurable and painful bowel condition after the National Institute for Health and Care Excellence (NICE) published new guidance for the NHS. For the first time ever, doctors have a clear guideline from NICE to make it easier to treat people with ulcerative colitis.
June 26, 2013

NICE issues guideline on the diagnosis and management of chronic hepatitis B
NICE has published its clinical guideline on the diagnosis and management of chronic hepatitis B.
June 26, 2013

NICE recommends new treatment option for potentially fatal blood clotting disease
NICE has issued final guidance recommending rivaroxaban as an option for treating pulmonary embolism (PE) and preventing recurrent deep vein thrombosis and PE after acute PE in adults.
June 26, 2013

NICE guidance on drug for severe gout
NICE, the health and social care guidance body, has published final guidance on a drug for severe gout.  The guidance does not recommend pegloticase (Krystexxa), within its marketing authorisation, for treating severe debilitating chronic tophaceous gout in adults.
June 26, 2013

NICE says yes to dapagliflozin for some people with type 2 diabetes in final guidance
In final guidance published today, NICE has recommended dapagliflozin (Forxiga, Bristol-Myers Squibb and Astra Zeneca) for some people with type 2 diabetes.
June 26, 2013

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.